Home / France / Phaxiam Therapeutics
Phaxiam Therapeutics
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
66 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
March 31, 2015 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| October 26, 2015 | GSA Capital Partners LLP | 1.60% | August 8, 2016 |
| October 23, 2015 | GSA Capital Partners LLP | 1.59% | August 8, 2016 |
| October 22, 2015 | GSA Capital Partners LLP | 1.60% | August 8, 2016 |
| October 12, 2015 | GSA Capital Partners LLP | 1.50% | August 8, 2016 |
| September 24, 2015 | GSA Capital Partners LLP | 1.40% | August 8, 2016 |
| August 21, 2015 | GSA Capital Partners LLP | 1.30% | August 8, 2016 |
| July 27, 2015 | GSA Capital Partners LLP | 1.20% | August 8, 2016 |
| June 22, 2015 | GSA Capital Partners LLP | 1.10% | August 8, 2016 |
| June 18, 2015 | GSA Capital Partners LLP | 1.09% | August 8, 2016 |
| June 16, 2015 | GSA Capital Partners LLP | 1.10% | August 8, 2016 |
| May 26, 2015 | GSA Capital Partners LLP | 1.00% | August 8, 2016 |
| May 19, 2015 | GSA Capital Partners LLP | 0.92% | August 8, 2016 |
| May 11, 2015 | GSA Capital Partners LLP | 0.81% | August 8, 2016 |
| April 27, 2015 | GSA Capital Partners LLP | 0.70% | August 8, 2016 |
| April 7, 2015 | GSA Capital Partners LLP | 0.61% | August 8, 2016 |
| March 31, 2015 | GSA Capital Partners LLP | 0.54% | August 8, 2016 |
Other companies sold short in France
- Ubisoft Entertainment 13.69% of the capital sold short
- Valeo 10.92% of the capital sold short
- Teleperformance 8.94% of the capital sold short
- FDJ United 6.67% of the capital sold short
- Renault 6.54% of the capital sold short
- Remy Cointreau 5.36% of the capital sold short
- Viridien 5.32% of the capital sold short
- Alstom 5.23% of the capital sold short
- Abivax 5.04% of the capital sold short
- Worldline 4.48% of the capital sold short
- Vusiongroup 4.08% of the capital sold short
- Forvia 4.06% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Phaxiam Therapeutics, source AMF, data as at December 16, 2021, https://www.quivad.com/action/phaxiam-therapeutics?page=2